Bladder cancer can develop without causing someone to feel noticeably sick, which is why recognizing potential warning signs ...
MIT researchers created a nanosensor catheter that detects bladder cancer biomarkers far earlier than current tests.
A 19-year-old woman with OHVIRA syndrome had a spontaneous bladder rupture discovered during surgery and underwent emergency ...
Women on CagriSema lost 25% of their body weight in a post hoc trial analysis, while 79.6% of users had digestive side effects. The drug is not approved. Ice Water, Math Quizzes, and Shocks: The 1948 ...
Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, ...
Transurethral cystolithotripsy and open surgery are associated with a high stone-free rate among bladder stone cases, though ...
The agency used a 'new approach' to broaden the drug's indication to include patients with BCG-unresponsive non-muscle invasive bladder cancer whose tumors are papillary-only.
Stanford Medicine researchers and collaborators developed an RNA-based urine test that could improve bladder cancer diagnosis ...
The approval adds patients with high-grade papillary-only tumors, based on trial data showing a 62% complete response rate in ...
Researchers in China have built an explainable deep learning model that analyzes contrast-enhanced CT scans to predict ...
The FDA extended Anktiva to high-grade papillary-only bladder cancer that no longer responds to BCG. Its reasoning rests on a ...